Skip to main content
    S

    Sonnet Biotherapeutics Holdings Inc (SONN)

    Official site

    BIOTECHNOLOGY

    $1.26
    -1.84 (-59.35%)

    Last updated: Dec 02, 2025 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    62%(18/29)
    Avg Surprise
    -7.99%
    Last 12 of 35 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Jun 25
    Reported Aug 13
    -$0.95-$0.49-$0.49 - -$0.49-93.88%Miss1
    1
    0
    30d
    -35.7%
    Mar 25
    Reported May 12
    -$0.89-$0.92-$0.92 - -$0.92+3.26%Beat1
    1
    0
    30d
    -1371.4%
    Dec 24
    Reported Feb 12
    -$1.56-$11.12-$11.12 - -$11.12+85.97%Beat1
    No revisions (30d)
    -403.2%
    Sep 24
    Reported Dec 12
    -$10.39-$5.52N/A-88.22%Miss---397.1%
    Jun 24
    Reported Aug 14
    -$0.70-$0.76-$0.77 - -$0.76+7.89%Beat2
    No revisions (30d)
    -438.5%
    Mar 24
    Reported May 14
    $0.07$0.14-$0.30 - $0.57-50.00%Miss2
    No revisions (30d)
    +120.6%
    Dec 23
    Reported Feb 14
    -$0.31-$0.90-$0.94 - -$0.86+65.56%Beat2
    No revisions (30d)
    +61.3%
    Sep 23
    Reported Dec 14
    -$2.09-$4.09N/A+48.90%Beat---25.1%
    Jun 23
    Reported Aug 14
    -$0.13-$0.31-$0.31 - -$0.31+58.06%Beat1
    No revisions (30d)
    +92.9%
    Mar 23
    Reported May 10
    -$0.34-$0.49-$0.56 - -$0.43+30.61%Beat2
    1
    0
    30d
    +82.7%
    Dec 22
    Reported Feb 13
    -$0.80-$1.10-$1.10 - -$1.10+27.27%Beat1
    No revisions (30d)
    +42.9%
    Sep 22
    Reported Dec 15
    -$1.67-$1.51N/A-10.60%Miss--+31.8%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 72.7% below its 50-day moving average. The 14-day RSI is 28.2, below 30, the oversold line.

    Moving Averages

    SMA 10$3.96
    SMA 20$4.35
    SMA 50$4.62
    SMA 200N/A
    EMA 10$3.65
    EMA 20$4.11
    EMA 50$4.36
    EMA 200$3.38

    MACD

    Line: -0.43Signal: -0.12Hist: -0.31

    ADX

    ADX: 12.8+DI: 14.2-DI: 36.4

    Aroon & PSAR

    Aroon Up60.0
    Aroon Down100.0
    PSAR$5.75

    Bollinger Bands

    Upper Band$6.33
    Lower Band$2.37
    %B Position9118%(Upper)
    Band Width-0.28

    RSI (14-Day)

    Oversold
    28.2

    Momentum Oscillators

    Stoch %K2.2
    Stoch %D10.0
    Williams %R-100.0
    ROC (10d)-76.4%
    Momentum-4.09
    CCI (20d)-306.4
    MFI (14d)34.2

    Volatility Measures

    ATR (14d)$0.88(70.1%)
    StdDev (20d)0.99
    Hist Vol305.3%(High)

    Volume Flow

    VWAP$1.92
    OBV183.5M
    AD Line44.2M
    CMF (20d)-0.282

    Volume Metrics

    Avg Vol (20d)1.3M
    Vol Ratio8.1x(High)
    VWMA (20d)$3.24

    Pivot Points

    R3$4.47
    R2$4.19
    R1$3.65
    Pivot Point$3.37
    S1$2.83
    S2$2.55
    S3$2.01

    Advanced Oscillators

    TSI-13.32
    Ultimate Osc37.6
    KST-97.97

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about SONN

    News

    No news available

    Company news will appear here when available

    Sonnet Biotherapeutics Holdings Competitors

    Peers by sector and size for Sonnet Biotherapeutics Holdings (SONN) include cbdMD, Biomx and Hoth Therapeutics.

    Sector: Healthcare

    SONN Earnings: Beat Rate

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    -2.6%

    Updated Dec 18, 2025. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About SONN

    Does SONN pay dividends?

    Sonnet Biotherapeutics Holdings Inc (SONN) does not currently pay a regular dividend.

    SONN pages: Overview, Financials

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.